• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

视神经脊髓炎

[Neuromyelitis optica].

作者信息

Ferrán Ceila, Pedemonte Virginia, Turcatti Emilio, González Gabriel

机构信息

Centro Hospitalario Pereira Rossell, Facultad de Medicina, Universidad de la República, Montevideo, Uruguay.

Centro Hospitalario Pereira Rossell, Facultad de Medicina, Universidad de la República, Montevideo, Uruguay. E-mail:

出版信息

Medicina (B Aires). 2019;79 Suppl 3:60-65.

PMID:31603846
Abstract

Neuromyelitis optica (NMO) is an autoimmune, inflammatory and de myelinat ing disorder of the central nervous system with a predilection for the optic nerves and spinal cord. In 2004 the association of NMO with an antibody against the water channel aquaporin 4 (anti-AQP4) was published as a different pathology from multiple sclerosis (MS). Currently the term NMO spectrum disorders (NMOSD) is proposed, because the manifestations of the disease can be more extensive, affecting in addition to the optic nerve and spinal cord, the area postrema of the dorsal medulla, brainstem, diencephalon and typical brain areas (periependymal, corpus callosum, internal capsule and subcortical white matter). NMOSD is also applied to patients who meet the NMO criteria and are negative for AQP4-IgG. Within the latter group, the presence of another antibody, anti-MOG, has been detected in 20%, with a different physiopathological mechanism, but with a similar clinic and a better prognosis. The immunosuppressive treatment in the attack, as well as the long-term treatment in the cases that are indicated, is fundamental to avoid sequelaes and recurrences. The correct diagnosis of this entity is essential since it can be aggravated with the use of drugs useful in the treatment of MS. In this publication we will review the pathophysiology, clinical and diagnostic criteria of NMOSD, and discuss the different therapeutic options.

摘要

视神经脊髓炎(NMO)是一种自身免疫性、炎症性和脱髓鞘性中枢神经系统疾病,好发于视神经和脊髓。2004年,NMO与抗水通道蛋白4抗体(抗AQP4)的关联被公布,被认为是一种与多发性硬化症(MS)不同的病理类型。目前提出了“NMO谱系障碍(NMOSD)”这一术语,因为该疾病的表现可能更广泛,除了视神经和脊髓外,还会影响延髓背侧最后区、脑干、间脑和典型脑区(室管膜周围、胼胝体、内囊和皮质下白质)。NMOSD也适用于符合NMO标准但AQP4-IgG阴性的患者。在后者中,已检测到20%的患者存在另一种抗体抗MOG,其病理生理机制不同,但临床表现相似且预后较好。发作期的免疫抑制治疗以及有指征病例的长期治疗对于避免后遗症和复发至关重要。正确诊断该疾病至关重要,因为使用对MS有效的药物可能会使其病情加重。在本出版物中,我们将回顾NMOSD的病理生理学、临床和诊断标准,并讨论不同的治疗选择。

相似文献

1
[Neuromyelitis optica].视神经脊髓炎
Medicina (B Aires). 2019;79 Suppl 3:60-65.
2
The Immunology of Neuromyelitis Optica-Current Knowledge, Clinical Implications, Controversies and Future Perspectives.视神经脊髓炎的免疫学——当前认知、临床意义、争议及未来展望
Int J Mol Sci. 2016 Mar 2;17(3):273. doi: 10.3390/ijms17030273.
3
What You Need to Know About AQP4, MOG, and NMOSD.AQP4、MOG 和 NMOSD 须知要点。
Semin Neurol. 2019 Dec;39(6):718-731. doi: 10.1055/s-0039-3399505. Epub 2019 Dec 17.
4
Neuromyelitis optica spectrum disorder: Pathogenesis, treatment, and experimental models.视神经脊髓炎谱系疾病:发病机制、治疗和实验模型。
Mult Scler Relat Disord. 2019 Jan;27:412-418. doi: 10.1016/j.msard.2018.12.002. Epub 2018 Dec 3.
5
Neuromyelitis optica spectrum disorders with antibodies to myelin oligodendrocyte glycoprotein or aquaporin-4: Clinical and paraclinical characteristics in Algerian patients.视神经脊髓炎谱系疾病伴髓鞘少突胶质细胞糖蛋白或水通道蛋白-4 抗体:阿尔及利亚患者的临床和辅助检查特征。
J Neurol Sci. 2017 Oct 15;381:240-244. doi: 10.1016/j.jns.2017.08.3254. Epub 2017 Aug 31.
6
Update on the diagnosis and treatment of neuromyelits optica spectrum disorders (NMOSD) - revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part I: Diagnosis and differential diagnosis.视神经脊髓炎谱系疾病(NMOSD)的诊断和治疗进展 - 视神经脊髓炎研究组(NEMOS)的修订建议。第一部分:诊断和鉴别诊断。
J Neurol. 2023 Jul;270(7):3341-3368. doi: 10.1007/s00415-023-11634-0. Epub 2023 Apr 6.
7
Brain and spinal cord lesion criteria distinguishes AQP4-positive neuromyelitis optica and MOG-positive disease from multiple sclerosis.脑和脊髓病变标准将 AQP4 阳性视神经脊髓炎和 MO G 阳性疾病与多发性硬化症区分开来。
Mult Scler Relat Disord. 2018 Oct;25:246-250. doi: 10.1016/j.msard.2018.08.008. Epub 2018 Aug 9.
8
The clinical value of complement proteins in differentiating AQP4-IgG-positive from MOG-IgG-positive neuromyelitis optica spectrum disorders.补体蛋白在区分 AQP4-IgG 阳性与 MOG-IgG 阳性视神经脊髓炎谱系疾病中的临床价值。
Mult Scler Relat Disord. 2019 Oct;35:1-4. doi: 10.1016/j.msard.2019.06.035. Epub 2019 Jun 29.
9
[Clinical characteristics and follow-up of pediatric patients with neuromyelitis optica and neuromyelitis optica spectrum disorders].视神经脊髓炎及视神经脊髓炎谱系障碍患儿的临床特征与随访
Zhonghua Er Ke Za Zhi. 2015 Apr;53(4):268-73.
10
Neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein IgG associated disorder: A comprehensive neuro-ophthalmic review.视神经脊髓炎谱系疾病和髓鞘少突胶质细胞糖蛋白 IgG 相关疾病:全面的神经眼科综述。
Clin Exp Ophthalmol. 2021 Mar;49(2):186-202. doi: 10.1111/ceo.13863. Epub 2021 Jan 10.

引用本文的文献

1
Discrepancy in clinical and laboratory profiles of NMOSD patients between AQP4 antibody positive and negative: can NMOSD be diagnosed without AQP4 antibody?视神经脊髓炎谱系疾病患者在临床和实验室特征上存在差异:是否可以在不检测水通道蛋白 4 抗体的情况下诊断视神经脊髓炎谱系疾病?
Clin Exp Immunol. 2023 Oct 13;213(3):363-370. doi: 10.1093/cei/uxad053.
2
Progress in treatment of neuromyelitis optica spectrum disorders (NMOSD): Novel insights into therapeutic possibilities in NMOSD.视神经脊髓炎谱系疾病(NMOSD)治疗进展:NMOSD 治疗可能性的新见解。
CNS Neurosci Ther. 2022 Jul;28(7):981-991. doi: 10.1111/cns.13836. Epub 2022 Apr 15.